Background: Severe acute kidney injury (AKI) occurs in 2-7% of all hospital admissions and is an independent poor prognostic marker. Nevertheless, information on the long-term outcome of AKI and the factors influencing this is limited. Aim: To describe the short-and long-term outcome of patients requiring renal replacement therapy (RRT) for severe AKI and to examine factors affecting patient survival and renal recovery. Design and methods: Single centre retrospective analysis of 481 consecutive patients over a period of 39 months. Follow-up: 12 months. Primary and secondary outcomes: overall mortality and RRT dependency at 30 days, 90 days and 1 year. Results: Survival at 30 days, 90 days and 1 year was 54.4, 47.2 and 37.6%, respectively. RRT independency at 30 days, 90 days and 1 year was 35.2, 27.2 and 25.8%, respectively. Of those RRT
Introduction
Acute kidney injury (AKI) remains a complex clinical entity of diverse aetiology and often variable severity resulting in an unpredictable outcome. The incidence of AKI requiring renal replacement therapy (RRT) is estimated to be 286 per million population per year. 1 Severe AKI occurs in $2-7% of all hospital admissions, 2, 3 and between 4% and 15% of patients admitted to intensive care develop AKI requiring RRT. [3] [4] [5] [6] Severe AKI requiring RRT is an independent poor prognostic marker and, not merely a reflection of the severity of underlying disease. 7, 8 AKI carries a significant in-patient mortality rate of 50-80%.
predictor of long-term morbidity, mortality and functional outcome. 10, 11 Residual renal impairment is prevalent in $30% of the survivors 12 with 12.5% still requiring on-going RRT at hospital discharge. 3 Shorter periods of RRT requirement, non-oliguria and better baseline renal function prior to the insult are reported to be associated with better outcome. 13 Previous epidemiological and outcome studies on AKI had reported varying ranges of incidence and survival outcomes as there was no consensus on the definition of AKI. With the emergence of a clear multilayered definition and classification of AKI using the RIFLE (risk injury failure loss end-stage renal disease) criteria developed by ADQI (acute dialysis quality initiative) in 2004, increasing numbers of studies have provided more unified data on epidemiology and survival outcome. [14] [15] [16] The RIFLE classification was not only reported to independently predict 30-day mortality, mechanical ventilation, inotropic support and RRT requirement among patients who were admitted with community acquired pneumonia, 17 but was also found to correlate with ITU outcome. 18 Mortality of patients with severe AKI has clearly improved from 1950s to 1980s; nevertheless, it has not shown further improvement over the past two decades. 19, 20 Literature from the UK on AKI has focused on the short-term renal and survival outcomes of patients with AKI during the acute episode with limited information on the long-term implications of AKI and the factors influencing this outcome, especially outside of the ITU setting. 1, 4, 5, [18] [19] [20] [21] [22] [23] The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) on AKI from 2009 examined the process of care of patients who died in hospital with AKI and demonstrated systemic failings in the recognition and management of AKI in the UK. 24 This study describes the short-and long-term outcome of patients with AKI requiring RRT (RIFLE category: F) and examines factors affecting patient survival and renal recovery in a single UK renal centre.
Subjects and methods
We performed a retrospective observational study of 481 consecutive patients who developed AKI treated with RRT over a period of 39 months (October 2004 to December 2007) in an 811-bed teaching hospital. We included all patients who received continuous veno-venous haemofiltration (CVVH) in the intensive care unit and those who received intermittent haemodialysis (IHD) for AKI in the renal unit. CVVH was performed at a prescribed rate of 30 ml/kg/h while IHD was performed three times per week for 4 h per session.
The follow-up period was 12 months. Data collection was conducted using the electronic patient record system (iCareVortal), local renal database (proton) and online biochemistry reporting system (ICE). Data collection comprised demographic details, diagnosis on admission, aetiology of AKI, the presence of underlying chronic kidney disease (CKD; recorded creatinine of >150 mmol/l within 90 days prior to admission), co-morbidity data (Charlson Index; CI) and mode of RRT used.
The primary and secondary outcomes were overall mortality and RRT dependency at 30 days, 90 days and 1 year. For those who survived at 90 days and remained RRT independent, estimated Glomerular Filtration Rate (eGFR) was recorded to examine the extent of residual renal impairment. Statistical analysis was performed using SPSS. To analyse the characteristics of the study population, the t-test was used for parametric interval variables (age, CI) while chi-square was used for categorical variables. We used a multivariate logistic regression model to identify independent predictors of patient survival and RRT independence at 30 days and at 1 year.
Results

Patient characteristics
The mean age was 65.3 (SD 15.5) years. Sixty-two per cent were male and 38% were female with a male to female ratio of 1.6:1. Of the patients, 85% were Caucasian. Mean CI score was 3.3 (SD 1.85). CKD prior to admission was present in 10.2% of the patients. Diabetes mellitus and malignancy were present in 23.3 and 16.6% of the patients, respectively. The commonest aetiology of AKI was due to pre-renal causes (64.9%), followed by intrinsic renal causes (24.5%) and post-renal causes (5.6%). In 5% of the cases, aetiology of AKI was unclear on documentation. Overall, 42.8% of AKI was attributed to sepsis. Other causes of AKI included post-operative AKI, obstructive nephropathy, vasculitis and nephrotoxin use.
Of the patients, 53.8% required CVVH in the intensive care setting for either the entire episode or at some point during the episode of AKI (Group A), while 46.2% received exclusive IHD (Group B). Patients in Group B were generally older [66.9 (SD 15.5) vs. 63.9 (SD 15.4) years] had a higher prevalence of known CKD (16.7% vs. 4.6%) and diabetes mellitus (27.9% vs. 19.3%), lower incidence of sepsis (27.5% vs. 57.5%) and 'pre-renal' AKI (43.9% vs. 88.1%) and higher incidence of 'intrinsic-renal' AKI during hospitalization (Table 1) .
Survival and renal recovery outcome
The overall patient survival at 30 days, 90 days and 1 year was 54.4, 47.2 and 37.6%, respectively. Among the survivors, 64.8, 72.8 and 74.2% of the patients were RRT independent at 30 days, 90 days and 1 year, correspondingly (Table 2) .
In view of the fact that patients in the two groups were inherently different owing to variable illness severity and the potential presence of multi-organ failure among the ITU patients (Group A), we have examined the survival and renal recovery outcome of both groups separately.
Patients in Group A had an overall high mortality with survival rates of 40. 
RRT independence
In total, 140 patients were RRT independent at 90 days (29%). For these patients, 61.4% of the eGFR values were available at 90 days. Despite being RRT independent, 41, 12 and 2% of the survivors were noted to have CKD Stages 3, 4 and 5 at 90 days, respectively (Table 3) .
Predictors of patient survival and renal outcomes
We also examined the impact of different demographic variables, co-morbidities, AKI aetiology and the presence of sepsis on survival and renal outcome at 30 days and 1 year. Undoubtedly, in our study population, those patients undergoing CVVH in the intensive care setting at any stage of their hospitalization (Group A) were distinctly different from those who only required IHD (Group B). This is also reflected in the survival and renal recovery seen in these two distinct groups (Table 2) . We, therefore, performed a multivariate logistic regression analysis to examine the predictive factors of the short-and long-term mortality and renal recovery outcomes in each group separately.
Survival outcome
In Group A, previous CKD, 'intrinsic-renal' cause of AKI and diabetes mellitus were noted to be independent predictors of better survival outcome for both short and long term, while female gender and a lower CI co-morbidity score predicted better long-term survival outcome at 1 year (Table 4) . In Group B, younger age was an independent predictor of survival across both endpoints (1 month and 1 year). Previous CKD and 'renal' or 'post-renal' cause of AKI also predicted better survival at 1 month while the absence of malignancy was an independent predictor of survival at 1 year (Table 5 ).
Renal outcome
In Group A, the presence of sepsis was an independent predictor of RRT independence at 1 year (Table 6 ). There was no statistically significant predictor of RRT independence at 1 month in Group A.
In Group B, 'pre-renal' cause of AKI and female gender were consistent independent predictors of higher rates of RRT independence at 1 month and 1 year. 'Post-renal' cause of AKI predicted better RRT independence at 1 month while previously known CKD predicted better RRT independence at 1 year (Table 7) .
Discussion
AKI carries a poor survival outcome in the short term, especially among the group of patients requiring intensive care support and has a significant lasting effect in the long term as nearly two out of three patients (62.4%) with AKI fail to survive at 1 year. This result is not dissimilar to that seen previously with a reported mortality rate of 57-80% at 1 year. 25, 26 Although patients who developed AKI needing RRT in ITU had a lower survival rate, the majority of those who survived did not require long-term RRT. This finding is comparable with other studies 19 and is likely to be attributable to the high proportion of 'pre-renal' AKI among this specific group of patients.
Severe AKI among those in Group B heralded a life-long requirement of RRT in as many as one out of four patients remaining RRT dependent at 1 year. This seemingly high dialysis dependence at 1 year in our study compared to others 27 may be due to the inclusion of patients with underlying CKD in our study group. However, a Scottish prospective study examining the incidence and outcome of AKI, including patients with a background of CKD, reported comparable RRT dependency at 90 days. 24 Previous studies have observed high frequency of end-stage renal failure and lower rates of mortality in those who develop severe AKI due to renal parenchymal disease, which is consistent with our findings in patients within Group B.
28
Among the survivors who were RRT independent, more than half of the patients were seen to have significant residual renal impairment (eGFR < 60), necessitating long-term renal monitoring and implicating a higher risk for cardiovascular disease. 27 Risk factors that predict mortality in patients with AKI requiring RRT in ITU have been identified as oliguria, acidosis, higher APACHE II (Acute Physiology and Chronic Health Evaluation II) score, the presence of pre-existing end-stage disease, reliance on mechanical ventilation, maximum number of failed organs, admission after emergency surgery and non-surgical admission. 5, 23, 29 The same is not true for predictors in patients with AKI treated outside of the ITU setting with risk factors for long-term renal dependence not fully characterized.
Using a multivariate logistic regression analysis to examine the independent predictors of survival, we found that advancing age, higher CI score and the presence of malignancy were associated with a higher mortality. On the other hand, patients with an 'intrinsic renal' pathology as the aetiology of AKI were noted to have better survival. Some, but not all of these, have previously been identified. 1, 29 Surprisingly, the presence of diabetes mellitus and previous CKD appeared to have a survival advantage in both groups. A plausible explanation of these observations may be that patients with an 'intrinsic-renal' cause of AKI and those with previous CKD may represent a subgroup of patients who sustained renal failure as single organ failure requiring RRT, as compared to patients who were commenced on RRT as part of supportive treatment for severe multi-organ failure, often secondary to overwhelming sepsis. Evidently, the later were associated with worse survival outcome. Alternatively, these findings may be due to the fact that other variables, which may have influenced the survival outcome, were not fully incorporated into the study. For instance, the APACHE II score, which is known to have an impact on survival outcome, was not included in this study.
Regarding RRT independence in the short-and long-term, pre-renal cause, female gender and sepsis were noted to predict higher RRT independence. Previously documented CKD also appeared to be one of the independent predictors of RRT dependence at 1 year. As AKI is a complex, heterogeneous condition encompassing a diverse aetiology and severity, to establish precise predictors of survival and RRT independence in the short-and long-term, future studies will require incorporation of a wider range of variables and elimination of potential confounding factors. The validity of the predictors postulated by multivariate analysis of this retrospective study may be compromised due to unaccounted confounding factors. With the emergence of various biomarkers for AKI in recent years, larger prospective longitudinal studies which can provide detailed phenotypical characteristics of patients with AKI are warranted to improve our insight into exact predictors of survival and renal recovery outcomes in the future.
In summary, we have highlighted the ongoing poor survival and renal outcome in patients with AKI requiring RRT. Prompt treatment of the underlying disease and early diagnosis and management of AKI at the initial stages (RIFLE stage R and I), aimed at preventing disease progression to the point of RRT requirement (RIFLE stage F), is paramount to improving patient outcome.
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